These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2046812)

  • 1. Short dwell times reduce the local defence mechanism of chronic peritoneal dialysis patients.
    Vlaanderen K; Bos HJ; de Fijter CW; Oe LP; van der Meulen J; Verbrugh HA; Beelen RH
    Nephron; 1991; 57(1):29-35. PubMed ID: 2046812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients.
    Vlaanderen K; de Fijter CW; Bos HJ; van der Meulen J; Beelen RH; Oe PL; Verbrugh HA
    Adv Perit Dial; 1989; 5():151-3. PubMed ID: 2577399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function.
    Alobaidi HM; Coles GA; Davies M; Lloyd D
    Nephrol Dial Transplant; 1986; 1(1):16-21. PubMed ID: 3110659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis.
    Gordon DL; Rice JL; Avery VM
    Eur J Clin Microbiol Infect Dis; 1990 Mar; 9(3):191-7. PubMed ID: 2338088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis.
    de Fijter CW; Verbrugh HA; Oe LP; Peters ED; van der Meulen J; Donker AJ; Verhoef J
    Kidney Int; 1992 Oct; 42(4):947-50. PubMed ID: 1453585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial peritoneal defence in automated peritoneal dialysis: advantages of tidal over continuous cyclic peritoneal dialysis?
    de Fijter CW; Verbrugh HA; Oe PL; Heezius EC; Verhoef J; Donker AJ
    Nephrol Dial Transplant; 1994; 9(2):156-62. PubMed ID: 8190329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis.
    Keane WF; Comty CM; Verbrugh HA; Peterson PK
    Kidney Int; 1984 Mar; 25(3):539-43. PubMed ID: 6376908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are intracellularly penetrating antibiotics warranted in CAPD-related peritonitis?
    de Fijter CW; Verbrugh HA; Heezius HC; van Bronswijk H; van der Meulen J; Oe PL; Donker AJ; Verhoef J
    Adv Perit Dial; 1989; 5():124-7. PubMed ID: 2577393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of mesothelial cells in peritoneal antibacterial defence.
    Muijsken MA; Heezius HJ; Verhoef J; Verbrugh HA
    J Clin Pathol; 1991 Jul; 44(7):600-4. PubMed ID: 1856294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal defence mechanisms and Staphylococcus aureus in patients treated with continuous ambulatory peritoneal dialysis (CAPD).
    Davies SJ; Yewdall VM; Ogg CS; Cameron JS
    Perit Dial Int; 1990; 10(2):135-40. PubMed ID: 2085598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of CAPD patients with a high incidence of peritonitis to intraperitoneal immunoglobulin therapy.
    Carozzi S; Nasini MG; Kunkl A; Cantarella S; Lamperi S
    ASAIO Trans; 1988; 34(3):635-9. PubMed ID: 3264176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis.
    Verbrugh HA; Keane WF; Hoidal JR; Freiberg MR; Elliott GR; Peterson PK
    J Infect Dis; 1983 Jun; 147(6):1018-29. PubMed ID: 6854062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific opsonic activity for staphylococci in peritoneal dialysis effluent during continuous ambulatory peritoneal dialysis.
    Nielsen H; Espersen F; Kharazmi A; Antonsen S; Ejlersen E; Joffe P; Pedersen FB
    Am J Kidney Dis; 1992 Oct; 20(4):372-5. PubMed ID: 1415206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal immunoglobulin (IG) treatment in prophylaxis of bacterial peritonitis in CAPD.
    Lamperi S; Carozzi S; Nasini MG
    Biomater Artif Cells Artif Organs; 1987; 15(1):151-9. PubMed ID: 3329538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phagocytosis and killing of suspended and adhered bacteria by peritoneal cells after dialysis.
    Calame W; Afram C; Blijleven N; Hendrickx RJ; Namavar F; Beelen RH
    Perit Dial Int; 1995; 15(8):320-7. PubMed ID: 8785229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsonic requirements of Staphylococcus epidermidis.
    Clark LA; Easmon CS
    J Med Microbiol; 1986 Aug; 22(1):1-7. PubMed ID: 3735386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritonitis prevention in CAPD.
    Carozzi S; Lamperi S
    Clin Nephrol; 1988; 30 Suppl 1():S45-8. PubMed ID: 3141093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of CAPD dialysate on the release of eicosanoids and cytokines from human peritoneal macrophages.
    Steinhauer HB; Brugger U; Atmanspacher R; Lubrich-Birkner I; Schollmeyer P
    Adv Perit Dial; 1992; 8():47-52. PubMed ID: 1361851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of IgG, C3 and transferrin with opsonising and bacteriostatic activity of peritoneal fluid from CAPD patients and the incidence of peritonitis.
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Nephrol Dial Transplant; 1987; 2(6):551-6. PubMed ID: 3126457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disturbed host defense in peritoneal cavity during CAPD: characterization of responsible factors in dwell fluid.
    Vanholder R; Lameire N; Waterloos MA; Van Landschoot N; De Smet R; Vogeleere P; Lambert MC; Vijt D; Ringoir S
    Kidney Int; 1996 Aug; 50(2):643-52. PubMed ID: 8840297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.